MannKind - Duane DeSisto
Next up, to inhaled insulin pioneer MannKind Corporation who announced former CEO and President of medical device company Insulet Corporation Duane DeSisto has been installed as CEO as of January 5.
DeSisto takes over from entrepreneur, philanthropist and company founder Alfred Mann who – at the age of nearly 90 – was standing in as CEO after Hakan Edstrom stood down from the position in November.
“Duane's experience will be instrumental as we seek to enhance the commercial opportunity for Afrezza and pursue additional product opportunities within our pipeline,” Mann – who remains Executive Chairman – said.
But DeSisto will be forced to hit the ground running as his commencement coincides with Sanofi’s exit from a commercialisation deal, leaving MannKind looking for a new partner for Afrezza. Read more here.